Otonomy Appoints Chief Compliance Officer
Otonomy, a clinical-stage bio-pharmaceutical company, has appointed Eric Loumeau as general counsel and chief compliance officer. Previously, Loumeau also served as general counsel and chief compliance officer for Hollis-Eden Pharmaceuticals, a publicly-traded biotechnology company. Details inside.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.